BioSpace News Archive

Genetown

Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon

Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT™ Drug-Coated Balloon (DCB).

March 1, 2024
·
6 min read
Deals

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share

NRx Pharmaceuticals, Inc. today announced that it entered into a definitive purchase agreement subject to standard closing conditions with an accredited investor to purchase approximately 2.7 million shares of unregistered common stock at $0.38 per share.

March 1, 2024
·
5 min read
Business

Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024

Cutera, Inc. today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024.

March 1, 2024
·
4 min read
NMPA Approves the NDA for CARsgen’s BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma

CARsgen Therapeutics Holdings Limited announces that today the National Medical Products Administration (“NMPA”) of China has approved the New Drug Application (“NDA”) for zevorcabtagene autoleucel.

March 1, 2024
·
6 min read
Pharm Country

Mitsubishi Tanabe Pharma America to Showcase Presentations on ALS Research at 2024 MDA Clinical & Scientific Conference

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of five abstracts in amyotrophic lateral sclerosis (ALS) at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held in Orlando, Fla., March 3-6.

March 1, 2024
·
7 min read
BioMidwest

Immunis.AI Announces Publication, in The Journal of Urology, of Results from Blood-Based Immune Profiling Study for Prostate Cancer Patients

IMMUNIS.AI, an immunogenomics company developing blood-based cancer surveillance technologies, today announced that results from a prostate cancer risk stratification study evaluating the company’s novel blood-based liquid biopsy platform were published in The Journal of Urology.

March 1, 2024
·
5 min read
Lone Star Bio

Tvardi Therapeutics to Participate at the Cowen 44th Annual Health Care Conference

Tvardi Therapeutics, Inc. (“Tvardi”), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced it will participate at the Cowen 44th Annual Health Care Conference with the management team holding one-on-one investor meetings on March 4, 2024.

March 1, 2024
·
1 min read
ACG Becomes the World’s First Capsule Manufacturing Factory to Join the Global Lighthouse Network Community 2023-24

- ACG Capsules Pithampur, India is ACG’s 1st lighthouse to join the community.

March 1, 2024
·
3 min read
NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences

NMD Pharma A/S today announces that it will present two posters at the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference 2024 and one poster and one oral presentation at the 4th Scientific International Congress on SMA 2024.

March 1, 2024
·
3 min read
Biotech Beach

ImmunoScape Leadership to Present at Upcoming March 2024 Industry Conferences

ImmunoScape, a biotechnology company focused on next-generation T Cell receptor -based immunotherapies, announced that members of its executive team will present at two upcoming conferences, BioCentury-BayHelix East-West Summit 2024 and The State of Precision Medicine 2024.

March 1, 2024
·
2 min read